ArticleJournal of experimental & clinical cancer research : CR2020

Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer.

Simona Camorani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.